MERS Update

An outbreak of Middle East respiratory syndrome in South Korea has now sickened more than 150, killing 19.

Written byKerry Grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

PIXABAY, SSALAEThe latest death toll from an outbreak of Middle East respiratory syndrome (MERS) in South Korea is up to 19, CNN reported Monday (June 15), with 154 people having contracted the illness. Another 5,500 people have been quarantined in their homes or in designated facilities.

Health officials are hopeful that quarantine measures will end the outbreak in South Korea by July, according to Voice of America. “At this point, everything is under control and if an additional cluster does not occur, the final date will be June 27th,” said Kwon Jun-Wook, MERS taskforce leader in the country’s Ministry of Health and Welfare.

The World Health Organization (WHO) last week (June 12) reported that scientists have sequenced the genome of the virus in the South Korean outbreak. “Preliminary analysis of these findings does not suggest that a more transmissible virus is emerging in Korea,” WHO stated on its website. “An explanation for the rapid expansion of Korea’s outbreak almost certainly lies elsewhere.”

All of the cases so far have been linked ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies